DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Long GV, Atkinson VG, Lo S. et al.
Long-term outcomes from the randomized phase II study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets): Anti-PD1 brain collaboration (ABC).
Annals of Oncology 2019;
30: v534
DOI: 10.1093/annonc/mdz255.001.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.